CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$787M
(+53%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
29.03%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Walmart
WMT
|
$3.08M |
| 3 |
Alibaba
BABA
|
$2.59M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 5 |
Intel
INTC
|
$2.07M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ross Stores
ROST
$49.3B
| $223K | 0.03% |
1,519
+842
| +124% | +$124K |
|
277
Maravai LifeSciences
MRVI
$341M
| $221K | 0.03% |
25,434
+10,142
| +66% | +$87.9K |
|
278
Microchip Technology
MCHP
$34.2B
| $219K | 0.03% |
2,437
+1,365
| +127% | +$122K |
|
|
SAGE
279
DELISTED
Sage Therapeutics
SAGE
| $217K | 0.03% |
11,554
+4,617
| +67% | +$86.5K |
|
280
Zentalis Pharmaceuticals
ZNTL
$123M
| $215K | 0.03% |
13,634
+5,446
| +67% | +$85.8K |
|
|
VERV
281
DELISTED
Verve Therapeutics
VERV
| $213K | 0.03% |
16,071
+7,256
| +82% | +$96.4K |
|
282
Old Dominion Freight Line
ODFL
$31.1B
| $211K | 0.03% |
962
+746
| +345% | +$116K |
|
283
Relay Therapeutics
RLAY
$709M
| $209K | 0.03% |
25,210
+10,953
| +77% | +$90.9K |
|
284
89bio
ETNB
$1.37B
| $208K | 0.03% |
17,900
+9,153
| +105% | +$107K |
|
285
American Electric Power
AEP
$58.8B
| $204K | 0.03% |
2,373
+1,321
| +126% | +$114K |
|
286
Kraft Heinz
KHC
$31.9B
| $202K | 0.03% |
5,472
+3,019
| +123% | +$111K |
|
287
BioCryst Pharmaceuticals
BCRX
$1.74B
| $201K | 0.03% |
39,639
+15,947
| +67% | +$81K |
|
288
Pacific Biosciences
PACB
$378M
| $200K | 0.03% |
53,448
+20,593
| +63% | +$77.2K |
|
289
Paychex
PAYX
$48.8B
| $200K | 0.03% |
1,629
+908
| +126% | +$112K |
|
290
Fastenal
FAST
$56.8B
| $199K | 0.03% |
2,581
+1,454
| +129% | +$112K |
|
291
Tyson Foods
TSN
$20B
| $199K | 0.03% |
3,388
-7,956
| -70% | -$467K |
|
292
EyePoint Pharmaceuticals
EYPT
$827M
| $194K | 0.02% |
9,393
+5,308
| +130% | +$110K |
|
293
Constellation Brands
STZ
$25.8B
| $194K | 0.02% |
713
| – | – |
|
294
Keurig Dr Pepper
KDP
$39.5B
| $193K | 0.02% |
6,259
+3,459
| +124% | +$107K |
|
295
Ocular Therapeutix
OCUL
$2.25B
| $193K | 0.02% |
21,199
+12,007
| +131% | +$109K |
|
296
Charter Communications
CHTR
$35.7B
| $190K | 0.02% |
655
+360
| +122% | +$105K |
|
297
ARS Pharmaceuticals
SPRY
$1.08B
| $189K | 0.02% |
18,453
+7,348
| +66% | +$75.1K |
|
298
GE HealthCare
GEHC
$33B
| $187K | 0.02% |
2,054
+1,151
| +127% | +$105K |
|
299
Innoviva
INVA
$1.32B
| $186K | 0.02% |
12,172
+4,762
| +64% | +$72.6K |
|
300
Arcutis Biotherapeutics
ARQT
$1.91B
| $184K | 0.02% |
18,614
+7,694
| +70% | +$76.2K |
|